Antegenes

Tartu, Estonia

Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.

$1.6M raised

Aug 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Antegenes raised?

Antegenes has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in August 2022.

Who are Antegenes's investors?

Antegenes's investors include Enterprise Estonia, EIT - European Institute of Innovation and Technology, Timo Rein, Peep Vain, Aare Kurist.

Where is Antegenes headquartered?

Antegenes is headquartered in Tartu, Estonia.

What does Antegenes do?

Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.

What stage is Antegenes at?

Antegenes is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 2, 2022.

MLA

"Antegenes — Funding & Investors." VCBacked, August 2, 2022, https://www.vcbacked.co/company/antegenes. Accessed July 2, 2026.

APA

VCBacked. (2022). Antegenes — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/antegenes

Wikipedia (cite web)

{{cite web |title=Antegenes — Funding & Investors |url=https://www.vcbacked.co/company/antegenes |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 2, 2022.